Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Q1 2025 Earnings Call Transcript May 21, 2025 Evogene Ltd. beats earnings expectations. Reported EPS is $-0.38, expectations ...

High-impact workshop on ‘Biotechnology Applications for Crop Improvement’ highlights genetically modified and gene-edited ...

Pacibekitug, an antibody targeting interleukin-6, hit the primary endpoint in the phase 2 Tranquility trial by sharply ...

Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical trials. LONDON, May 22, 2025 /PRNewswire/ -- Comac ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...

NUCSER, a premier academic institution at Nitte University, is committed to advancing scientific education with ...

Skanska has signed an additional contract with the University of Virginia for the construction of the Paul and Diane Manning Institute of Biotechnology at Fontaine Research Park in Charlottesville, ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility Tuesday in Smithfield.

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.